1 week Ago By Defense World Staff
Corebridge Financial Inc. cut its position in shares of Alignment Healthcare, Inc. ( NASDAQ:ALHC – Free Report ) by 7.
0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,761 shares of the company’s stock after selling 3,756 shares during the period. Corebridge Financial Inc.
’s holdings in Alignment Healthcare were worth $560,000 as of its most recent filing with the Securities & Exchange Commission. Several other hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co.
raised its holdings in shares of Alignment Healthcare by 249.3% in the third quarter. JPMorgan Chase & Co.
now owns 288,219 shares of the company’s stock valued at $3,407,000 after acquiring an additional 205,705 shares in the last quarter. Principal Financial Group Inc. increased its position in Alignment Healthcare by 1,335.
1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after purchasing an additional 180,522 shares during the period.
The Manufacturers Life Insurance Company raised its holdings in shares of Alignment Healthcare by 132.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company’s stock valued at $1,524,000 after purchasing an additional 73,402 shares in the last quarter.
Barclays PLC lifted its position in shares of Alignment Healthcare by 144.1% in the 3rd quarter. Barclays PLC now owns 193,446 shares of the company’s stock worth $2,287,000 after purchasing an additional 114,191 shares during the period.
Finally, US Bancorp DE boosted its stake in shares of Alignment Healthcare by 6,544.2% during the fourth quarter. US Bancorp DE now owns 98,932 shares of the company’s stock valued at $1,113,000 after purchasing an additional 97,443 shares in the last quarter.
86.19% of the stock is currently owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In A number of research firms have weighed in on ALHC.
JPMorgan Chase & Co. upped their target price on Alignment Healthcare from $14.00 to $17.
00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Stephens reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday, February 24th.
William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Barclays increased their price target on shares of Alignment Healthcare from $8.00 to $9.
00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Finally, Bank of America lifted their price objective on shares of Alignment Healthcare from $15.50 to $18.
50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.
com, the stock has a consensus rating of “Moderate Buy” and an average price target of $14.83. Alignment Healthcare Stock Down 1.
6 % NASDAQ:ALHC opened at $17.82 on Tuesday. The company has a current ratio of 1.
60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.
Alignment Healthcare, Inc. has a twelve month low of $4.62 and a twelve month high of $18.
97. The company has a market cap of $3.42 billion, a PE ratio of -23.
14 and a beta of 1.32. The company’s 50 day moving average is $15.
69 and its two-hundred day moving average is $13.29. Insider Activity In other news, CEO John E.
Kao sold 554,713 shares of the firm’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.53, for a total value of $8,614,692.
89. Following the completion of the transaction, the chief executive officer now directly owns 4,733,664 shares in the company, valued at $73,513,801.92.
This trade represents a 10.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website .
Also, insider Robert L. Scavo sold 2,864 shares of the company’s stock in a transaction that occurred on Thursday, March 27th. The shares were sold at an average price of $17.
89, for a total value of $51,236.96. Following the completion of the sale, the insider now owns 702,953 shares in the company, valued at approximately $12,575,829.
17. This represents a 0.41 % decrease in their position.
The disclosure for this sale can be found here . Insiders have sold 1,981,855 shares of company stock valued at $30,590,612 over the last ninety days. 6.
60% of the stock is currently owned by insiders. Alignment Healthcare Profile ( Free Report ) Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans.
The company was founded in 2013 and is based in Orange, California. Featured Stories Five stocks we like better than Alignment Healthcare What is the Nikkei 225 index? Options Activity Points to More Volatility for Palantir Stock Utilities Stocks Explained – How and Why to Invest in Utilities NVIDIA Stock: Oversold, Undervalued — How Low Can It Go? How to Invest in Small Cap Stocks MicroStrategy Sees Insider Buy-Sell Action in Q1 Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc.
( NASDAQ:ALHC – Free Report ). Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter .
.
